Assignee
MEDIMMUNE LTD
GB·171 granted patents·155 pending applications·1,250 citations·filing 2003–2025
Top patents by PatentIndex Score
326 records- 0197US10646584B2Pyrrolobenzodiazepines and conjugates thereofMEDIMMUNE LTD·Filed 2019·Granted May 12, 2020·8 cites·8 claims
- 0297US7521051B2Methods of upmodulating adaptive immune response using anti-PD-1 antibodiesMEDIMMUNE LTD·Filed 2003·Granted Apr 21, 2009·376 cites·15 claims
- 0396US12121590B2Pyrrolobenzodiazepines and conjugates thereofMEDIMMUNE LTD·Filed 2023·Granted Oct 22, 2024·1 cites·16 claims
- 0496US9376440B2Pyrrolobenzodiazepines as antiproliferative agentsMEDIMMUNE LTD·Filed 2013·Granted Jun 28, 2016·37 cites·20 claims
- 0595US10035843B2RSV-specific binding moleculeMEDIMMUNE LTD·Filed 2016·Granted Jul 31, 2018·10 cites·20 claims
- 0695US9624227B2Unsymmetrical pyrrolobenzodiazepine-dimers for treatment of proliferative diseasesMEDIMMUNE LTD·Filed 2014·Granted Apr 18, 2017·26 cites·17 claims
- 0795US9493565B2Targeted binding agents against B7-H1MEDIMMUNE LTD·Filed 2014·Granted Nov 15, 2016·50 cites·8 claims
- 0895US9415117B2Pyrrolobenzodiazepines and conjugates thereofMEDIMMUNE LTD·Filed 2013·Granted Aug 16, 2016·31 cites·19 claims
- 0995US8877189B2Binding members for interleukin-4 receptor alpha (IL-4Rα) - 173MEDIMMUNE LTD·Filed 2013·Granted Nov 4, 2014·49 cites·15 claims
- 1095US7973140B2Antibodies directed to angiopoietin-2 and uses thereofMEDIMMUNE LTD·Filed 2005·Granted Jul 5, 2011·36 cites·11 claims
- 1194US9938356B2Binding molecules specific for CD73 and uses thereofMEDIMMUNE LTD·Filed 2015·Granted Apr 10, 2018·26 cites·9 claims
- 1294US9670521B2Amino acid derivativesMEDIMMUNE LTD·Filed 2013·Granted Jun 6, 2017·22 cites·13 claims
- 1394US9562049B2Pyrrolobenzodiazepines and conjugates thereofMEDIMMUNE LTD·Filed 2013·Granted Feb 7, 2017·29 cites·23 claims
- 1494US9399641B2Pyrrolobenzodiazepines as unsymmetrical dimeric PBD compounds for inclusion in targeted conjugatesMEDIMMUNE LTD·Filed 2012·Granted Jul 26, 2016·28 cites·76 claims
- 1594US9388187B2PyrrolobenzodiazepinesMEDIMMUNE LTD·Filed 2012·Granted Jul 12, 2016·28 cites·14 claims
- 1693US12173050B2RSV-specific antibodies and functional parts thereofMEDIMMUNE LTD·Filed 2023·Granted Dec 24, 2024·1 cites·21 claims
- 1793US11286294B2Anti-RSV monoclonal antibody formulationMEDIMMUNE LTD·Filed 2021·Granted Mar 29, 2022·3 cites·30 claims
- 1893US10662239B2Antibodies to amyloid betaMEDIMMUNE LTD·Filed 2017·Granted May 26, 2020·9 cites·12 claims
- 1993US10010624B2Pyrrolobenzodiazepine-antibody conjugatesMEDIMMUNE LTD·Filed 2014·Granted Jul 3, 2018·9 cites·11 claims
- 2093US9283274B2RSV specific binding moleculeMEDIMMUNE LTD·Filed 2013·Granted Mar 15, 2016·9 cites·34 claims
- 2192US11286297B2Antibodies to amyloid betaMEDIMMUNE LTD·Filed 2020·Granted Mar 29, 2022·4 cites·17 claims
- 2292US9956298B2Pyrrolobenzodiazepines and conjugates thereofMEDIMMUNE LTD·Filed 2014·Granted May 1, 2018·24 cites·14 claims
- 2392US9732084B2Pyrrolobenzodiazepines used to treat proliferative diseasesMEDIMMUNE LTD·Filed 2013·Granted Aug 15, 2017·19 cites·19 claims
- 2492US9649390B2Pyrrolobenzodiazepines and conjugates thereofMEDIMMUNE LTD·Filed 2014·Granted May 16, 2017·19 cites·13 claims
- 2592US9399073B2PyrrolobenzodiazepinesMEDIMMUNE LTD·Filed 2012·Granted Jul 26, 2016·24 cites·17 claims
- 2691US10287362B2Binding molecules specific for CD73 and uses thereofMEDIMMUNE LTD·Filed 2018·Granted May 14, 2019·10 cites·15 claims
- 2791US10059757B2RSV-specific binding molecules and means for producing themMEDIMMUNE LTD·Filed 2016·Granted Aug 28, 2018·8 cites·32 claims
- 2891US9950078B2Pyrrolobenzodiazepine-antibody conjugatesMEDIMMUNE LTD·Filed 2014·Granted Apr 24, 2018·7 cites·11 claims
- 2991US9321774B2PyrrolobenzodiazepinesMEDIMMUNE LTD·Filed 2013·Granted Apr 26, 2016·28 cites·20 claims
- 3090US11203633B2Polynucleotides encoding antibodies or antigen binding fragments thereof that bind pseudomonas pervMEDIMMUNE LTD·Filed 2020·Granted Dec 21, 2021·2 cites·25 claims
- 3190US10774133B2Anti-RSV monoclonal antibody formulationMEDIMMUNE LTD·Filed 2018·Granted Sep 15, 2020·7 cites·42 claims
- 3290US10736903B2Pyrrolobenzodiazepine-anti-PSMA antibody conjugatesMEDIMMUNE LTD·Filed 2013·Granted Aug 11, 2020·5 cites·6 claims
- 3390US10730931B2RSV-specific binding molecules and means for producing themMEDIMMUNE LTD·Filed 2018·Granted Aug 4, 2020·3 cites·34 claims
- 3490US10400039B2Targeted binding agents against B7-H1MEDIMMUNE LTD·Filed 2016·Granted Sep 3, 2019·8 cites·8 claims
- 3590US9834598B2Antibodies to amyloid betaMEDIMMUNE LTD·Filed 2013·Granted Dec 5, 2017·9 cites·7 claims
- 3690US8858942B2Antibodies directed to ERBB2MEDIMMUNE LTD·Filed 2012·Granted Oct 14, 2014·11 cites·12 claims
- 3789US11446292B2Compounds and conjugates thereofMEDIMMUNE LTD·Filed 2021·Granted Sep 20, 2022·2 cites·15 claims
- 3889US10954308B2Antibodies to ticagrelor and methods of useMEDIMMUNE LTD·Filed 2018·Granted Mar 23, 2021·4 cites·30 claims
- 3989US10844114B2Anti-Pseudomonas Psl binding molecules and uses thereofMEDIMMUNE LTD·Filed 2019·Granted Nov 24, 2020·3 cites·21 claims
- 4089US10723786B2RSV-specific binding moleculeMEDIMMUNE LTD·Filed 2018·Granted Jul 28, 2020·3 cites·19 claims
- 4189US9284589B2Methods of obtaining a specific binding member that binds eotaxinMEDIMMUNE LTD·Filed 2014·Granted Mar 15, 2016·9 cites·12 claims
- 4289US8350011B2Antibodies to ErbB2MEDIMMUNE LTD·Filed 2007·Granted Jan 8, 2013·10 cites·7 claims
- 4388US9321831B2RSV-specific binding molecules and means for producing themMEDIMMUNE LTD·Filed 2013·Granted Apr 26, 2016·8 cites·23 claims
- 4488US7947273B2Human antibody molecules for IL-13MEDIMMUNE LTD·Filed 2007·Granted May 24, 2011·10 cites·18 claims
- 4588US2025179153A1Rsv-specific antibodies and functional parts thereofMEDIMMUNE LTD·Filed 2024·Application pending·0 cites
- 4687US12344664B2Antibodies to amyloid betaMEDIMMUNE LTD·Filed 2024·Granted Jul 1, 2025·0 cites·20 claims
- 4787US10751346B2Pyrrolobenzodiazepine—anti-PSMA antibody conjugatesMEDIMMUNE LTD·Filed 2013·Granted Aug 25, 2020·4 cites·10 claims
- 4887US10695433B2Pyrrolobenzodiazepine-antibody conjugatesMEDIMMUNE LTD·Filed 2013·Granted Jun 30, 2020·4 cites·8 claims
- 4987US10370436B2Anti-pseudomonas Psl binding molecules and uses thereofMEDIMMUNE LTD·Filed 2016·Granted Aug 6, 2019·5 cites·5 claims
- 5087US10335497B2Pyrrolobenzodiazepines and conjugates thereofMEDIMMUNE LTD·Filed 2017·Granted Jul 2, 2019·3 cites·6 claims
Showing the top 50 of 326 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →